Christopher J. Kane, MD, FACS, presented “High-Risk Localized and Oligometastatic Disease” during the 34th International Prostate Cancer Update on February 12, 2024, in Vail, Colorado.
This content is available free to the GRU Community. Login or create an account to view it.
How to cite: Kane, Christopher J. “High-Risk Localized and Oligometastatic Disease.” February 2024. Accessed Nov 2024. https://grandroundsinurology.com/high-risk-localized-and-oligometastatic-disease/
High-Risk Localized and Oligometastatic Disease – Summary
Christopher J. Kane, MD, FACS, provides an overview of current best practices in detecting and treating high-risk localized and oligometastatic prostate cancer. In this presentation, he reviews:
- The diagnostic value of PSMA PET versus nodal dissection
- The overall survival rates of patients treated with ADT plus XRT versus ADT alone
- The risks of long-term ADT
About The 34th Annual International Prostate Cancer Update:
The International Prostate Cancer Update (IPCU), founded in 1990, is a multi-day CME conference focused on prostate cancer treatment updates with expert, international faculty. It is led by expert physicians and is designed for urologists, medical oncologists, radiation oncologists, and other healthcare professionals involved in the diagnosis and treatment of prostate cancer. The 34th iteration of the meeting occurred February 11-14, 2024 in Vail, Colorado. To view more educational presentations from IPCU 34, visit our collection page.
